sign in sign up
<<
Home , Betamethadol, Hydromorphinol, Phenomorphan

Federal Register / Vol. 71, No. 117 / Monday, June 19, 2006 / Notices 35311

Any other such applicant and any Drug Schedule Drug Schedule person who is presently registered with DEA to manufacture such a substance 4-Bromo-2,5- I 1-Phenylcyclohexylamine (7460) II may file comments or objections to the dimethoxyphenethylamine (7471) ...... II issuance of the proposed registration (7392). 1- II pursuant to 21 CFR 1301.33(a). 4-Methyl-2,5- I Piperidinocyclohexanecarbonitr- dimethoxyamphetamine (7395). ile (8603). Any such written comments or 2,5-Dimethoxyamphetamine I Alphaprodine (9010) ...... II objections being sent via regular mail (7396). (9041) ...... II may be addressed, in quintuplicate, to 2,5-Dimethoxy-4- I (9050) ...... II the Deputy Assistant Administrator, ethylamphetamine (7399). (9120) ...... II Office of Diversion Control, Drug 3,4-Methylenedioxyamphetamine I (9143) ...... II (7400). (9150) ...... II Enforcement Administration, 5-Methoxy-3,4- I Washington, DC 20537, Attention: DEA (9170) ...... II methylenedioxyamphetamine Benzoylecgonine (9180) ...... II Federal Register Representative, Liaison (7401). (9190) ...... II and Policy Section (ODL); or any being N-Hydroxy-3,4- I (9193) ...... II sent via express mail should be sent to methylendioxyamphetamine (9210) ...... II DEA Headquarters, Attention: DEA (7402). (9220) ...... II Federal Register Representative/ODL, 3,4-Methylendioxy-N- I (9226) ...... II 2401 Jefferson-Davis Highway, ethylamphetamine (7404). Meperidine (9230) ...... II Alexandria, Virginia 22301; and must be 3,4- I (9250) ...... II Methylenedioxymethamphetam- filed no later than August 18, 2006. Methadone intermediate (9254) ... II ine (7405). , bulk (non- II Dated: June 9, 2006. 4-Methoxyamphetamine (7411) ... I dosage forms) (9273). Joseph T. Rannazzisi, Bufotenine (7433) ...... I (9300) ...... II Diethyltryptamine (7434) ...... I Deputy Assistant Administrator, Office of (9333) ...... II Dimethyltryptamine (7435) ...... I Levo- (9648) .. II Diversion Control, Drug Enforcement Psilocybin (7437) ...... I Administration. (9652) ...... II Psilocyn (7438) ...... I (9668) ...... II [FR Doc. E6–9508 Filed 6–16–06; 8:45 am] (9051) ...... I Racemethorphan (9732) ...... II BILLING CODE 4410–09–P (9052) ...... I (9737) ...... II Codeine-N-oxide (9053) ...... I (9740) ...... II (9145) ...... I (9801) ...... II DEPARTMENT OF JUSTICE (9200) ...... I (9301) ...... I Drug Enforcement Administration (9304) ..... I The company plans to manufacture Morphine-N-oxide (9307) ...... I small quantities of the listed controlled Manufacturer of Controlled (9313) ...... I substances to make reference standards (9314) ...... I which will be distributed to their Substances; Notice of Registration (9601) ...... I (9602) ...... I customers. By Notice dated January 11, 2006, and Alphacetylmethadol except levo- I No comments or objections have been published in the Federal Register on alphacetylmethadol (9603). received. DEA has considered the January 23, 2006 (71 FR 3543), Cerilliant Alphameprodine (9604) ...... I factors in 21 U.S.C. 823(a) and (9605) ...... I determined that the registration of Corporation, 811 Paloma Drive, Suite A, (9607) ...... I Round Rock, Texas 78664, made Betameprodine (9608) ...... I Cerilliant Corporation to manufacture application by renewal to the Drug (9609) ...... I the listed basic classes of controlled Enforcement Administration (DEA) to Betaprodine (9611) ...... I substances is consistent with the public be registered as a bulk manufacturer of (9627) ...... I interest at this time. DEA has the basic classes of controlled (9633) ...... I investigated Cerilliant Corporation to substances listed in Schedules I and II: (9634) ...... I ensure that the company’s registration is (9635) ...... I consistent with the public interest. The (9646) ...... I Drug Schedule investigation has included inspection (9647) ...... I Para-Fluorofentanyl (9812) ...... I and testing of the company’s physical Cathinone (1235) ...... I 3-Methylfentanyl (9813) ...... I security systems, verification of the Methcathinone (1237) ...... I Alpha-Methylfentanyl (9814) ...... I company’s compliance with state and N-Ethylamphetamine (1475) ...... I Acetyl-alpha-methylfentanyl I local laws, and a review of the N,N-Dimethylamphetamine (1480) I (9815). company’s background and history. Aminorex (1585) ...... I Beta-hydroxyfentanyl (9830) ...... I Therefore, pursuant to 21 U.S.C. 823, 4-Methylaminorex (cis isomer) I Beta-hydroxy-3-methylfentanyl I and in accordance with 21 CFR 1301.33, (1590). (9831). Gamma Hydroxybutyric acid I the above named company is granted Alpha-Methylthiofentanyl (9832) ... I registration as a bulk manufacturer of (2010). 3-Methylthiofentanyl (9833) ...... I Methaqualone (2565) ...... I (9835) ...... I the basic classes of controlled Alpha-Ethyltryptamine (7249) ...... I Amphetamine (1100) ...... II substances listed. Lysergic acid diethylamide (7315) I Methamphetamine (1105) ...... II Dated: June 12, 2006. Marihuana (7360) ...... I Phenmetrazine (1631) ...... II Joseph T. Rannazzisi, (7370) ..... I Methylphenidate (1724) ...... II Mescaline (7381) ...... I Amobarbital (2125) ...... II Deputy Assistant Administrator, Office of 3,4,5-Trimethoxyamphetamine I Pentobarbital (2270) ...... II Diversion Control, Drug Enforcement (7390). Secobarbital (2315) ...... II Administration. 4-Bromo-2,5- I Glutethimide (2550) ...... II [FR Doc. E6–9504 Filed 6–16–06; 8:45 am] dimethoxyamphetamine (7391). (7379) ...... II BILLING CODE 4410–09–P

VerDate Aug<31>2005 16:46 Jun 16, 2006 Jkt 208001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM 19JNN1 jlentini on PROD1PC65 with NOTICES